Introduction
============

Oroidin (**1**) is a major metabolite of several species of marine sponges of the genus *Agelas* and is the basis of the oroidin group of alkaloids. It was first isolated in 1971 from *Agelas* *oroides* \[[@B1-molecules-06-00130]\] but its structure misassigned. A revised structure was established in 1973 \[[@B2-molecules-06-00130]\] and proven by total synthesis in 1986 \[[@B3-molecules-06-00130]\]. Subsequently, many other species of *Agelas, Axinella, Acanthella, Hymeniacidon, Phakellia* and *Pseudaxinyssa* have been reported to contain high levels of oroidin or cyclic analogues. It is thus clear that oroidin alkaloids are useful chemotaxonomic markers for axinellid sponges that were once allied with the Agelasida.

In 1981, Faulkner and co-workers \[[@B4-molecules-06-00130]\] isolated sceptrin (**2**) from *Agelas* *sceptrum.* Formally, sceptrin is related to debromooroidin by a head-to-head \[2 + 2\]-cycloaddition that must be photochemically allowed. As oroidin is achiral, if this were a photochemical reaction, sceptrin ought to have been isolated as a racemic mixture. In contrast, sceptrin is chiral (\[α\]~D~ - 7.4°) suggesting that it is formed by an enzyme catalysed reaction. If this is the case, it will be the first example of a biological \[2 + 2\] cycloaddition or, indeed, any pericyclic reaction. Slight variations on the structure of sceptrin (eg dibromosceptrin, debromosceptrin, oxysceptrin (**3**) and nakamuric acid (**4**)) have been isolated in subsequent work from *Agelas* cf *nemoechinata* \[[@B5-molecules-06-00130]\], *A. conifer* \[[@B6-molecules-06-00130]\] and *A. nakamurai* \[[@B7-molecules-06-00130]\].

These compounds are also of pharmaceutical interest as many have shown α-adrenoceptor blocking activity that does not interfere with the action of potassium chloride or seratonin \[[@B8-molecules-06-00130]\]. Specifically, sceptrin (**2**), and its analogues have potent antibacterial/antifungal activities \[[@B9-molecules-06-00130]\], anti-muscarinic activity \[[@B10-molecules-06-00130]\], anti-histaminic activity \[[@B11-molecules-06-00130]\] and oxysceptrin is also a potent actomyosin ATPase activator \[[@B5-molecules-06-00130]\]. As a first step toward isolation of enzymes involved in the biosynthesis of sceptrin, we need to find a local sponge that contains this compound.

![LCMS traces for *Agelas* sp. 1A. A) UV trace at 280 nm. B) Positive ion mass chromatogram of *m/z* 621. Sceptrin elutes as a broad peak due to the two very basic guanidinium groups. C) Positive ion mass chromatogram of *m/z* 637. D) Positive ion mass chromatogram of *m/z* 189+191. Many other bromopyrroles also contain these peaks as a fragment. E) Positive ion mass chromatogram of *m/z* 584. F) Negative ion mass chromatogram of *m/z* 268.](molecules-06-00130-g001){#molecules-06-00130-f001}

Results and Discussion
======================

Four specimens of *Agelas* spp were collected in Western Australia, extracted, and the crude extracts, (after treatment) were subject to analysis by analytical HPLC and LC-MS. The results are summarised in [Table 1](#molecules-06-00130-t001){ref-type="table"} and [Table 2](#molecules-06-00130-t002){ref-type="table"}. Only *Agelas* sp. 1A (WAM Z1194) showed evidence of sceptrin. [Figure 1](#molecules-06-00130-f001){ref-type="fig"}A shows the HPLC trace (UV; 280 nm) of the extract, sceptrin eluting as a very broad peak ([Fig 1](#molecules-06-00130-f001){ref-type="fig"}B) with a molecular ion at *m/z* 619/621/623. A doubly charged ion is evident at *m/z* 311. The MS-MS of the 621 peak is shown in [Fig. 2](#molecules-06-00130-f002){ref-type="fig"}A. Note the loss of 172, characteristic of the bromo-2-pyrrolecarbonyl fragment. Subsequent loss of ammonia yields a fragment at *m/z* 431/433. The next major peak corresponds to oxysceptrin (**3**) with a retention time of 14.4 min. ([Fig. 1](#molecules-06-00130-f001){ref-type="fig"}C) and a molecular ion at *m/z* 635/637/639. The major fragmentations of **3** ([Fig 2](#molecules-06-00130-f002){ref-type="fig"}B) showed loss of 172 then 17 like sceptrin. Peaks for 4-bromo-2-pyrrolecarboxamide (14.2; [Figure 1](#molecules-06-00130-f001){ref-type="fig"}D), nakamuric acid (**4**) (20.7; [Figure 1](#molecules-06-00130-f001){ref-type="fig"}E) and 4,5-dibromo-2-pyrrolecarboxylic acid (26.2 min.; [Figure 1](#molecules-06-00130-f001){ref-type="fig"}F) followed, the latter characteristically giving a strong negative ion spectrum. Nakamuric acid (20.7 min.) was characterised by a molecular ion at *m/z* 582/584/586. MS-MS of the 584 amu peak ([Fig. 2](#molecules-06-00130-f002){ref-type="fig"}C) again showed loss of 172 (as for sceptrin and oxysceptrin) but subsequent loss of water (18) instead of ammonia (17) was observed.

![MS-MS of individual compounds from *Agelas* sp. 1A. A) Sceptrin, precursor ion *m/z* 621. B) Oxysceptrin, precursor ion *m/z* 637, C) Nakamuric acid, precursor ion *m/z* 584. The most intense ion of the molecular ion cluster was used for MS-MS analysis as this ion contained both the 79 and 81 isotopes of bromine and hence fragments that still contained a bromine atom could be readily identified.](molecules-06-00130-g002){#molecules-06-00130-f002}

molecules-06-00130-t001_Table 1

###### 

Major peaks from LC-MS from *Agelas* sp. 1 (A and B) with tentative structural assignments.

  -------- ------------------- -------- --------------------------------------
           *Agelas* sp. 1A              
  **RT**   **Molecular ion**   **MW**   **Tentative structure**
  10.8     619/621/623         618      sceptrin (**2**)
  14.2     189/191             188      4-bromopyrrole-2-carboxamide
  14.4     635/637/639         634      oxysceptrin (**3**)
  15.4     687/689/691         686      oxysceptrin acetate
  16.6     679/681/683         678      
  17.8     610/612/614         609      
  18.5     642/644/646         641      
  19.3     596/598/600         595      
  20.7     582/584/586         581      nakamuric acid (**4**)
  26.2     266/268/270\*       267      4,5-dibromopyrrole 2-carboxylic acid
           *Agelas* sp. 1B              
  14.5     189/191             188      4 (or 5?)-bromopyrrole-2-carboxamide
  17.9     635/637/639         634      oxysceptrin (**3**)
  19.2     619/621/623         618      sceptrin (**2**)
  19.2     687/689/691         678      oxysceptrin acetate
  19.9     357/359\*           358      
  21.1     265/267/269\*       266      4,5-dibromopyrrole 2-carboxamide
  22.5     582/584/586         581      nakamuric acid (**4**)
  24.9     266/268/270\*       267      4,5-dibromopyrrole 2-carboxylic acid
  -------- ------------------- -------- --------------------------------------

\* observed as negative ion

![HPLC chromatogram (UV 280 nm) of *Agelas* sp. 1B. LCMS indicated essentially the same compounds were present as in *Agelas* sp. 1A ([Table 1](#molecules-06-00130-t001){ref-type="table"}).](molecules-06-00130-g003){#molecules-06-00130-f003}

![LCMS traces for *Agelas* sp. 2. A) UV trace at 280 nm. B) Positive ion mass chromatogram of *m/z* 358. Manzacidine B elutes as a sharp peak. C) Positive ion mass chromatogram of *m/z* 344. D) Positive ion mass chromatogram of *m/z* 406. Note that there are several isomers with this weight. E) Positive ion mass chromatogram of *m/z* = 450. Unidentified compounds with two bromines. F) Positive ion mass chromatogram of *m/z* = 353 - possibly longamide B.](molecules-06-00130-g004){#molecules-06-00130-f004}

The five peaks eluting between oxysceptrin and nakamuric acid did not correspond to any known metabolite though each contained two bromine atoms and the peak at 16.6 min (*m/z* 679/681/683) is consistent with a monoacetate of sceptrin.

The same compounds were observed in *Agelas* sp. 1B ([Fig 3](#molecules-06-00130-f003){ref-type="fig"}). There were several other compounds present that contained two bromines and their molecular ions did not correspond to any compounds in our database of oroidin-like (or *Agelas* spp) compounds.

*Agelas* sp. 2 contained completely different compounds ([Fig 4](#molecules-06-00130-f004){ref-type="fig"}). The peaks eluting at 16.1 ([Fig. 4](#molecules-06-00130-f004){ref-type="fig"}B) and 16.4 min. ([Fig. 4](#molecules-06-00130-f004){ref-type="fig"}C) corresponded to compounds **5** of the manzacidine family \[[@B12-molecules-06-00130]\] where the R was a hydrogen (*m/z* 344/346) or keto (*m/z* 358/360 - a new compound). Structurally similar compounds; longamide A (**6**) and B (**7**) \[[@B13-molecules-06-00130]\] were also detected (18.4 and 25.6 min.; [Fig. 4](#molecules-06-00130-f004){ref-type="fig"}F).

The other major compound (m/z 404/406/408; 17.5 min.; [Fig. 4](#molecules-06-00130-f004){ref-type="fig"}D) contained two bromine atoms and its mass spectrum corresponds to dihydrospongiacidine (**8**) or an isomer of which there are several known \[[@B14-molecules-06-00130]\]. Minor components included at least two isomers of 3-bromohymenialdosine (**8**) (18.9 and 20.2 min.; [Fig. 4](#molecules-06-00130-f004){ref-type="fig"}D; m/z 402/404/406) which could be E/Z isomers about the exocyclic double bond. Such compounds have been previously isolated from *Stylissa* *carteri* \[[@B15-molecules-06-00130]\]. Several other unidentified compounds of this type were also observed and are likely to be new (eg MW 447; [Fig. 4](#molecules-06-00130-f004){ref-type="fig"}E).

Finally, *Agelas* cf *mauritiana*, contained many compounds with bromine ([Fig. 5](#molecules-06-00130-f005){ref-type="fig"}). Evidence for bromohymenialdisine and a hydrogenated forms (**8**), eluting at 19.0 ([Fig. 5](#molecules-06-00130-f005){ref-type="fig"}C) and 19.9/21.5 min. (*m/z* 402/404/406 and 404/406/408; [Fig. 5](#molecules-06-00130-f005){ref-type="fig"}B). The remaining compounds were so similar to *Agelas* sp. 2 that we were led to conclude that they must be identical sponges.

molecules-06-00130-t002_Table 2

###### 

Major peaks from LC-MS from *Agelas* sp. 2 and *Agelas* cf *mauritiana*.

  -------- -------------------------- -------- ------------------------------------
           *Agelas* sp. 2                      
  **RT**   **Molecular ion**          **MW**   **Tentative structure**
  16.1     358/360                    357      manzacidine B (**5**)
  16.4     346/348                    345      manzacidine A (**5**)
  17.5     404/406/408                403      dihydrospongiacidine (**8**)
  18.4     309/311/313                308      longamide A (**6**)
  18.9     402/404/406                401      bromohymenialdisine (**8**)
  19.1     420/421/423                419      
  20.2     402/404/406                401      bromohymenialdisine isomer (**8**)
  20.3     448/450/452                447      
  20.7     267/269/271                266      4,5-dibromopyrrole carboxamide
  22.7     448/450/452                447      
  23.8     323/325/327\*              324      
  25.4     379/381/383                378      
  25.6     351/353/355                350      longamide B (**7**)
  26.2     266/268/270\*              267      4,5-dibromopyrrole carboxylic acid
  28.5     294/296/298\*              295      
           *Agelas* cf *mauritiana*            
  17.5     346/348                    345      manzacidine A (**5**)
  19.0     404/406/408                403      dihydrospongiacidine (**8**)
  19.4     309/311/313                308      longamide A (**6**)
  19.9     402/404/406                401      bromohymenialdisine (**8**)
  20.5     420/422/424                419      
  21.5     402/404/406                401      bromohymenialdisine isomer (**8**)
  21.6     448/450/452                447      
  23.1     267/269/271                266      4,5-dibromopyrrole carboxamide
  23.8     446/448/450                267      
  24.6     323/325/327\*              324      
  25.9     365/367/369\*              366      
  26.6     266/268/270\*              267      4,5-dibromopyrrole carboxylic acid
  29.2     294/296/298\*              295      
  -------- -------------------------- -------- ------------------------------------

\* observed as negative ion

![LCMS analysis of *Agelas* cf *mauritiana*. A) HPLC UV trace (280 nm). B) mass selective HPLC trace at *m/z* 404 and C) *m/z* 406.](molecules-06-00130-g005){#molecules-06-00130-f005}

Conclusion
==========

Reliable taxonomy can lead quickly to the discovery of compounds that may be of interest. In this case, we have, for the first time in Australian waters isolated compounds that could have arisen from a \[2 + 2\] photoaddition. The next step in this project is to make fresh collections of this sponge and try and establish an assay, using sceptrin, for the enzyme(s) responsible for dimerisation. These may be of use in organic synthesis and are of considerable scientific interest. In addition, we have evidence that all the sponges collected in this study contain new compounds that have, as yet, not been described. This is based on MS and UV evidence and future work will involve isolation and structure elucidation of these novel compounds. LC-MS was also found to be an excellent method of natural product dereplication - quickly identifying known compounds and signaling the presence of potentially new ones. The results of the chemical analyses were also able to show that the four sponges collected appear to belong to only two species, not three as indicated by the classical taxonomy. This emphasises the difficulties in sponge taxonomy at the species level, a result of few morphologically distinguishing features.

Epilogue
========

Perhaps compounds of the sceptrin type are not produced through a pericyclic reaction. An alternative polar conjugate addition ([Fig 6](#molecules-06-00130-f006){ref-type="fig"}) could be envisaged but this is not as interesting.

![Possible polar mechanism, involving two sequential conjugate additions catalysed by protonation of one oroidin molecule.](molecules-06-00130-g006){#molecules-06-00130-f006}

Experimental
============

Collection
----------

*Agelas* sp. 1A (WAM Z1194), *Agelas* sp. 1B (WAM Z1193), and *Agelas* cf *mauritiana* (WAM Z1200) were all collected at Rat Island, Houtman Abrolhos Islands at 3-13m depth on 5 December 1996. All sponges were bright orange alive, thickly encrusting to mound shapes, and all occurred in semi-shade. WAM Z1194 was reproductive containing eggs WAM Z1193 was not reproductive, it was a slightly darker orange and slightly more contractile texture than Z1194. It also had more spicules in its primary fibres than Z1194, but this was not assessed quantitatively. *Agelas* sp. 2 (WAM Z17) was collected from Beacon Island, Houtman Abrolhos Islands. It was collected at \~20 m depth on 20 March 1997. It was not reproductive, was also an orange mound sponge, but had morphological, skeletal and spicule differences from the other material.

Analysis of morphology, colour and spiculation led to the conclusion that Z1194 and Z1193 were the same species but in one was a reproductively active female and the other specimen was not. The other two species were clearly different even though all were thickly encrusting orange sponges.

Extraction
----------

All specimens were steeped in ethanol soon after collection. The ethanol was decanted after two months and replaced with fresh ethanol. After a further week, the second extract was combined with the first and both allowed to evaporate to dryness. The crude extracts (\~ 50 mg) were dissolved in a minimum of methanol/dichloromethane and made up to 2 mL with water. The methanol and dichloromethane were evaporated by boiling and the cooled extract loaded on to a C18 Sep-Pak which had been washed with methanol and 25% methanol water and finally equilibrated in water. The milky extract was loaded onto the column and the eluant recycled three times. The column was then eluted with water (5 mL) and then 90% methanol/water. The first 1 mL that eluted with the stronger solvent was used for LC-MS analysis.

Mass spectrometry
-----------------

Liquid chromatography-mass spectrometry was performed on a Quattro II, triple quadrupole mass spectrometer (Micromass, UK) fitted with an electrospray source. The RP-HPLC was performed on a HP 1090 LC using a Waters Nova-pak 4μ C18 (2 mm × 150 mm) column. UV detection was provided by a ABI Analytical Spectroflow 757 variable wavelength detector. The UV output was monitored at 280 nm and the UV trace was acquired by the Masslynx data system (Micromass) along with the MS data. A split placed after the UV detector directed approximately 20% of the flow to the mass spectrometer. Solvent A was MilliQ water, solvent B was UV grade methanol. A flow rate of 0.2 mL/min. was used. Two alternating mass spectrum scans were employed. In the positive ion mode the instrument was scanned from *m/z* 100 to *m/z* 1000 in 3 seconds at a cone voltage of 35 V. In the negative ion mode the instrument was scanned from *m/z* 120 to *m/z* 1000 in 3 seconds at a cone voltage of 30 V. The high voltage applied to the ESI capillary was 3.5 kV and 3.0 kV for the positive and negative ion modes respectively.

High performance liquid chromatography
--------------------------------------

HPLC was performed on a Waters 2690 system using a Waters "Symmetry" C18 column which gives good peak shapes even for strongly basic compounds. In an attempt to isolate just the alkaloids, the crude extracts (\~ 300 mg) were dissolved in 2 mL of ethanol and made up to 20 mL with water. The solutions were adjusted to pH 3 and extracted with dichloromethane (3 × 10 mL). The remaining aqueous layer was adjusted to pH 12 then extracted with ethyl acetate (3 × 20 mL). The combined ethyl acetate layers were washed with water, evaporated and filtered through a C18 Sep-Pak (100% methanol).

*Sample Availability:* Not available.
